Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 20 citations · 17 references
MedicineHematologyPharmacologyCancer PharmacologyKidney TransplantationOncology PharmacotherapyToxicity ManagementTransplant ComplicationsTransplant PharmacologyTransplant-related ToxicitiesCohort Study InvestigationHigh-dose Methotrexate PharmacokineticsHigh-dose Methotrexate TherapyMethotrexate NephrotoxicityMethotrexate Toxicity PreventionSalvage Combination TherapyTransplantationTransplantation Outcome Assessment
= 41) developed extra-renal toxicity (leading to the death of two patients) despite early administration. Thus, severe toxicity and death can occur whether or not glucarpidase is administered, which confirms the need for further interventional studies to provide greater precision on its role in the management of HD-MTX toxicity.
17
Khê Hoang‐Xuan, Luc Taillandier, Olivier Chinot et al. · Journal of Clinical Oncology · 2003 · 263 citations
Medicine, Oncology, Pharmacology +15